|Bid||93.75 x 800|
|Ask||93.76 x 1800|
|Day's Range||93.39 - 94.30|
|52 Week Range||81.78 - 109.98|
|Beta (3Y Monthly)||0.46|
|PE Ratio (TTM)||53.55|
|Earnings Date||Feb 19, 2019|
|Forward Dividend & Yield||2.08 (2.23%)|
|1y Target Est||107.00|
Amazon's stock has been on a tear this year. One analyst sees the stock going even higher. Yahoo Finance’s Alexis Christoforous and Heidi Chung break down the details.
Walmart, McDonald's, CBS, Credit Suisse and Dave & Buster's are the companies to watch.
Just a few years ago, retailers considered smartphones the enemy of the in-store experience they were trying to create. Today, stores are taking their cues from shoppers and now consider the smartphone their friend. Nike created a buzz last month when it unveiled two new features on its mobile app during the opening of its latest high tech store in New York City.
US equity markets rallied sharply in 2016 after President Trump was elected. There was a sharp rally in metal prices. Before President Trump’s election, base metals like copper and aluminum were trading in a narrow range. President Trump was expected to save US manufacturing, especially steel, from the onslaught of imports.
Holding Co. have extended their network agreement to provide access to Walmart’s prescription services for Express Scripts clients’ covered members. The three-year agreement will help both insured and uninsured customers save money on prescription drugs, the companies said Wednesday. Walmart also will participate in Express Scripts’s pharmacy-savings program called InsideRx, which provides discounts, on average of 40%, to uninsured Americans using brand-name prescription drugs.
Shares of Walmart Inc. and Express Scripts Holding Co. rose in premarket trade Wednesday, after the two announced a three-year agreement to provide cheaper medications to underinsured and uninsured Americans. Walmart will have access to Express Scripts' lower pricing on dozens of brand-name prescription drugs. The pharmacy benefits manager will offer its InsideRx, which provides discounts of an average of 40% to uninsured customers on brand-name prescription drugs. Express Scripts shares rose 1.2% premarket and have gained 29% in 2018, while the S&P 500 has fallen 1.4%.
BENTONVILLE, Ark. and ST. LOUIS, Dec. 12, 2018 /PRNewswire/ -- Today, Walmart and Express Scripts (ESRX) announced an extension to the companies' existing network agreement to provide access to Walmart's prescription services for Express Scripts clients' covered members. The companies also made a commitment to deliver additional affordable prescription solutions to millions of underinsured and uninsured Americans. As part of the ongoing relationship, Walmart is partnering with Express Scripts' to access their unique pricing on dozens of brand-name prescription drugs, and create additional value for its customers. As one example, Express Scripts has introduced a novel solution – InsideRx -- to provide discounts, on average 40%, to uninsured Americans on a growing number of important brand-name prescription drugs.
New data compiled by "bug bounty" company Bugcrowd shows that hackers can now command up to $500,000 per year testing security flaws at companies that hire them. Bug bounty companies provide a platform for hackers to safely chase security flaws at companies that want to be tested. Freelance elite hackers can make more than $500,000 a year searching for security flaws and reporting those issues at big companies like Tesla and organizations like the Department of Defense, according to new data released by ethical hacking platform Bugcrowd.
Sainsbury's (SBRY.L) and Asda, the British supermarket groups that want to combine their businesses, will challenge a refusal by the regulator probing their 7.3 billion pound ($9.2 billion) deal to give them longer to respond to the latest evidence. The move sent shares in Sainsbury's down as much as 5.5 percent as it pointed to growing tension between the two companies and the Competition and Markets Authority (CMA) regulator. Sainsbury's Chief Executive Mike Coupe had already said last month that the firm would challenge in the courts any unfavourable final ruling by the CMA on the deal if it believed it was not backed up by published evidence.
Large companies view climate change as an increasing risk to their bottom lines and reputations among consumers and investors, according to a new analysis.